Evidence map›Paper›PMID 39861681›Full record

ArticlePharmaceutics2024

Tenascin C-Guided Nanosystem for Precision Delivery of Obeticholic Acid in Liver Fibrosis Therapy.

Yawen Wang, Lei Yang, Qing Xu, Taiyu Liu, Hongliang He, Lisha Liu, Lifang Yin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yawen WangDepartment of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China.
Lei YangDepartment of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China.
Qing XuDepartment of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China.
Taiyu LiuDepartment of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China.
Hongliang HeState Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Sciences & Medical Engineering, Southeast University, Nanjing 210009, China.ORCID 0000-0002-6099-4356
Lisha LiuDepartment of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China.ORCID 0000-0003-2056-0286
Lifang YinDepartment of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China.

Funding

Innovation and Entrepreneurship Training Program for Undergraduate in China Phar-maceutical University 3322400182National Center of Technology Innovation for Biopharmaceuticals NCTIB2022HS01015National Natural Science Foundation of China 82304422Natural Science Foundation of Jiangsu Province BK20221043
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antifibrotic nanomedicinehepatic inflammationobeticholic acidTnC-triggered sequential delivery

Identifiers

PMID39861681
PMCPMC11768695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.